Lupus kidney care program
Part of Immune system & allergy, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This study tests a care pathway for people with lupus-related kidney disease. It aims to provide better follow-up and treatment through telemedicine visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a diagnosis of systemic lupus erythematosus (SLE), an autoimmune disease
- You have active lupus-related kidney disease (called lupus nephritis), either new or ongoing
- You are a patient at a Duke University Health System clinic
- You can attend telemedicine visits (video or phone appointments)
- You are able to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well the kidneys survive over time in people with lupus nephritis. It uses medical records from the past 2–5 years to understand what affects kidney health.
This study looks at two simple blood tests to predict whether people with lupus nephritis (a kidney disease caused by lupus) may need intensive care or have a higher risk of dying in the hospital. It aims to help doctors identify who needs closer monitoring.
This study creates a registry for people with lupus and their families. It helps researchers learn more about lupus and improve care. You or your child can join if you have a lupus diagnosis.
This study follows patients with lupus nephritis (kidney inflammation caused by lupus) over time to learn more about the disease and improve care. You may join if you have had a kidney biopsy confirming lupus nephritis at this hospital.
This trial tests two biologic drugs (belimumab or telitacicept) compared to a standard treatment (mycophenolate mofetil) for people with active lupus nephritis. The goal is to see if biologics work better at controlling kidney inflammation over 6 months.
This study looks at a simple urine test to see if it can show how active lupus nephritis (kidney inflammation caused by lupus) is. It might help doctors monitor the condition without needing repeated biopsies.
Hear when a new Lupus Nephritis (LN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.